Antiretroviral therapy coverage for PMTCT in Lesotho

Lesotho: Antiretroviral therapy coverage for PMTCT was 94.0% in 2024. ◆ Volatile

Latest (2024)
94.0%
Change on year
up 6.8%
World rank
18th
of 84 countries
All-time high
100.0%
in 2015
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Lesotho, 2000–2024

0204060801002000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 0 % of pregnant women living with HIV2003: 0 % of pregnant women living with HIV2004: 3 % of pregnant women living with HIV2005: 6 % of pregnant women living with HIV2006: 17 % of pregnant women living with HIV2007: 30 % of pregnant women living with HIV2008: 17 % of pregnant women living with HIV2009: 48 % of pregnant women living with HIV2010: 65 % of pregnant women living with HIV2011: 90 % of pregnant women living with HIV2012: 91 % of pregnant women living with HIV2013: 89 % of pregnant women living with HIV2014: 97 % of pregnant women living with HIV2015: 100 % of pregnant women living with HIV2016: 96 % of pregnant women living with HIV2017: 82 % of pregnant women living with HIV2018: 93 % of pregnant women living with HIV2019: 97 % of pregnant women living with HIV2020: 100 % of pregnant women living with HIV2021: 97 % of pregnant women living with HIV2022: 90 % of pregnant women living with HIV2023: 88 % of pregnant women living with HIV2024: 94 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

In 2024, antiretroviral therapy coverage for pmtct in Lesotho stood at 94.0%.

Compared with earlier readings it is up 6.8% on the previous year and down 3.1% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Lesotho peaked at 100.0% in 2015 and was at its lowest, 0.0%, in 2000.

That places Lesotho 18th out of 84 countries with data for 2024, putting it in the top quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Lesotho, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Lesotho, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 3.0%
2005 6.0% +100.0%
2006 17.0% +183.3%
2007 30.0% +76.5%
2008 17.0% -43.3%
2009 48.0% +182.4%
2010 65.0% +35.4%
2011 90.0% +38.5%
2012 91.0% +1.1%
2013 89.0% -2.2%
2014 97.0% +9.0%
2015 100.0% +3.1%
2016 96.0% -4.0%
2017 82.0% -14.6%
2018 93.0% +13.4%
2019 97.0% +4.3%
2020 100.0% +3.1%
2021 97.0% -3.0%
2022 90.0% -7.2%
2023 88.0% -2.2%
2024 94.0% +6.8%

Lesotho compared with similar countries

  • Lesotho's 94.0% is above the median for lower middle income countries, which is 83.5%, 1.1× the median. (32 countries reporting)
  • Lesotho's 94.0% is above the median for Sub-Saharan Africa, which is 82.0%, 1.1× the median. (41 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Lesotho changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2006 +183.3% 6.0% 17.0%
2009 +182.4% 17.0% 48.0%
2005 +100.0% 3.0% 6.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 12.1% 0.0% 48.0% 10
2010s 90.0% 65.0% 100.0% 10
2020s 93.8% 88.0% 100.0% 5

Countries ranked near Lesotho

  1. 15 Malawi 96.0% compare
  2. 15 Portugal 96.0% compare
  3. 15 Romania 96.0% compare
  4. 18 Senegal 94.0% compare
  5. 20 Sierra Leone 93.0% compare
  6. 20 Zimbabwe 93.0% compare

See the full ranking of 99 places →

More health data for Lesotho

All data for Lesotho →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Lesotho?
Antiretroviral therapy coverage for pmtct in Lesotho was 94.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Lesotho?
The highest recorded value was 100.0% in 2015.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Lesotho?
The lowest recorded value was 0.0% in 2000.
How does Lesotho rank for antiretroviral therapy coverage for pmtct?
Lesotho ranks 18th out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Lesotho?
Over the last ten years it is down 3.1%. The long-run trend across the full record is volatile.
Where does this Lesotho data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Lesotho. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 17 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/lesotho/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/lesotho/">Antiretroviral therapy coverage for PMTCT in Lesotho</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).